Research ArticleArticle
Orexin-A Activates Hypothalamic AMP-Activated Protein Kinase Signaling through a Ca2+-Dependent Mechanism Involving Voltage-Gated L-Type Calcium Channel
Wen-Ning Wu, Peng-Fei Wu, Jun Zhou, Xin-Lei Guan, Zui Zhang, Yuan-Jian Yang, Li-Hong Long, Na Xie, Jian-Guo Chen and Fang Wang
Molecular Pharmacology December 2013, 84 (6) 876-887; DOI: https://doi.org/10.1124/mol.113.086744
Wen-Ning Wu
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Peng-Fei Wu
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Jun Zhou
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Xin-Lei Guan
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Zui Zhang
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Yuan-Jian Yang
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Li-Hong Long
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Na Xie
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Jian-Guo Chen
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
Fang Wang
Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, Hubei, China (W.-N.W., P.-F.W., J.Z., X.-L.G., Z.Z., Y.-J.Y., L.-H.L., N.X., J.-G.C., F.W.); Key Laboratory of Neurologic Diseases (HUST), Ministry of Education of China, The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province, Wuhan, China (P.-F.W., L.-H.L., N.X., J.-G.C., F.W.); and Department of Pharmacology, Anhui Medical University, Hefei, China (W.-N.W.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
L-Type Ca2+ Channel Mediates Hypothalamic AMPK Activation
Wen-Ning Wu, Peng-Fei Wu, Jun Zhou, Xin-Lei Guan, Zui Zhang, Yuan-Jian Yang, Li-Hong Long, Na Xie, Jian-Guo Chen and Fang Wang
Molecular Pharmacology December 1, 2013, 84 (6) 876-887; DOI: https://doi.org/10.1124/mol.113.086744
Research ArticleArticle
L-Type Ca2+ Channel Mediates Hypothalamic AMPK Activation
Wen-Ning Wu, Peng-Fei Wu, Jun Zhou, Xin-Lei Guan, Zui Zhang, Yuan-Jian Yang, Li-Hong Long, Na Xie, Jian-Guo Chen and Fang Wang
Molecular Pharmacology December 1, 2013, 84 (6) 876-887; DOI: https://doi.org/10.1124/mol.113.086744
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement